Related Experiment Video
Updated: Oct 1, 2025
11:09
Chromatin Isolation by RNA Purification ChIRP
Published on: March 25, 2012
87.0K
Unlocking the secrets of long non-coding RNAs in asthma.
Fien Gysens1, Pieter Mestdagh1, Eric de Bony de Lavergne1
1OncoRNALab, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Thorax
|March 5, 2022
Summary
Long non-coding RNAs (lncRNAs) show promise as biomarkers for distinguishing asthma subtypes and as potential therapeutic targets for severe, therapy-resistant asthma. Further research is needed to explore their full potential in asthma management.
Area of Science:
- Molecular Biology
- Immunology
- Respiratory Medicine
Background:
- Asthma is a complex, heterogeneous disease with subtypes like eosinophilic and neutrophilic asthma.
- Accurate phenotyping and endotyping are crucial for managing severe asthma refractory to standard treatments.
- Current biomarkers for asthma subtypes lack clarity and objectivity, necessitating new diagnostic and therapeutic strategies.
Purpose of the Study:
- To review the role of long non-coding RNAs (lncRNAs) in asthma.
- To explore the potential of lncRNAs as biomarkers for asthma subtypes and severity.
- To discuss lncRNAs as novel therapeutic targets for therapy-resistant asthma.
Main Methods:
- Literature review focusing on studies investigating lncRNAs in asthma.
- Analysis of research on lncRNA expression profiles in different asthma phenotypes.
- Examination of functional studies (in vivo and in vitro) elucidating lncRNA mechanisms.
Main Results:
- Many lncRNAs are differentially expressed in asthma patients.
- Specific lncRNAs have been linked to asthma severity and inflammatory phenotypes.
- Functional studies have begun to reveal the mechanisms of action for certain lncRNAs.
Conclusions:
- lncRNAs represent a promising area for identifying novel biomarkers in asthma.
- lncRNAs hold potential as therapeutic targets for severe and therapy-resistant asthma.
- Further research is essential to fully understand and utilize lncRNAs in asthma management.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
640
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
640
01:26Asthma-II: Pathophysiology and Classification
3.2K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.2K
01:20Asthma: Pathogenesis and Management
793
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
793
01:20Types of RNA
6.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
633
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
633